Disruption of the Endothelial Barrier by Proteases from the Bacterial Pathogen Pseudomonas aeruginosa: Implication of Matrilysis and Receptor Cleavage

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Beaufort, Nathalie ^a,b,e   Corvazier, Elisabeth ^a,b   Mlanaoindrou, Saouda ^a,b   de Bentzmann, Sophie ^c,d   Pidard, Dominique ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CNRS   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; METALLOPROTEINASE; METALLOPROTEINASE LASB; OCCLUDIN; PHOSPHORAMIDON; PROTEINASE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ADULT; ANOIKIS; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL ADHESION; CELL DISRUPTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIAL BARRIER DISRUPTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MESENCHYME CELL; NONHUMAN; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; VASCULAR ENDOTHELIUM;

BACTERIAL PROTEINS; CELL ADHESION; CELL DEATH; CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MEMBRANE TRANSPORT PROTEINS; METALLOENDOPEPTIDASES; PEPTIDE HYDROLASES; PROTEOLYSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SECRETORY VESICLES; TIGHT JUNCTIONS;

EID: 84884359440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075708     Document Type: Article

References (73)

1. van Hinsbergh VWM, Engelse MA, Quax PHA, (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26: 716-728. doi:10.1161/01.ATV.0000209518.58252.17. PubMed: 16469948.
2. Adams MN, Ramachandran R, Yau M-K, Suen JY, Fairlie DP, et al. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol Therapeut 130: 248-282. doi:10.1016/j.pharmthera.2011.01.003. PubMed: 21277892.
3. Okajima K, Abe H, Binder BR, (1995) Endothelial cell injury induced by plasmin in-vitro. J Lab Clin Med 126: 377-384. PubMed: 7561447.
4. Davis GE, Pintar Allen KA, Salazar R, Maxwell SA, (2000) Matrix metalloproteinase-1 and-9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 114: 917-930. PubMed: 11181175.
5. Frisch SM, Ruoslahti E, (1997) Integrins and anoikis. Curr Opin Cell Biol 9: 701-706. doi:10.1016/S0955-0674(97)80124-X. PubMed: 9330874.
6. Lindstedt KA, Leskinen MJ, Kovanen PT, (2004) Proteolysis of the pericellular matrix: a novel element determining cell survival and death in the pathogenesis of plaque erosion and rupture. Arterioscler Thromb Vasc Biol 24: 1350-1358. doi:10.1161/01.ATV.0000135322.78008.55. PubMed: 15191939.
7. Houard X, Leclercq A, Fontaine V, Coutard M, Martin-Ventura B, et al. (2006) Retention and activation of blood-borne proteases in the arterial wall. J Am Coll Cardiol 48: A3-A9. doi:10.1016/j.jacc.2006.04.098.
8. Taddei ML, Giannoni E, Fiaschi T, Chiarugi P, (2012) Anoikis: an emerging hallmark in health and diseases. J Pathol 226: 380-393. doi:10.1002/path.3000. PubMed: 21953325.
9. Hippenstiel S, Suttorp N, (2003) Interaction of pathogens with the endothelium. Thromb Haemost 89: 18-24. PubMed: 12540949.
10. Valbuena G, Walker DH, (2006) The endothelium as a target for infections. Annu Rev Pathol Mech Dis 1: 171-198.
11. Sahni SK, (2007) Endothelial cell infection and hemostasis. Thromb Res 119: 531-549. doi:10.1016/j.thromres.2006.06.006. PubMed: 16875715.
12. Lemichez E, Lecuit M, Nassif X, Bourdoulous S, (2010) Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat Rev Microbiol 8: 93-104. PubMed: 20040916.
13. Pier GB, Ramphal R, (2005) Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, Bennet's principles and practice of infectious diseases. 6th edition. Philadelphia: Elsevier Churchill Livingstone. pp. pp. 2587-2615.
14. Van Delden C, (2007) Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int J Antimicrob Ag 30S: S71-S75. PubMed: 17698326.
15. Strateva T, Mitov I, (2011) Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections. Ann Microbiol 61: 717-732. doi:10.1007/s13213-011-0273-y.
16. Matsumoto K, (2004) Role of bacterial proteases in pseudomonal and serratial keratitis. Biol Chem 385: 1007-1016. PubMed: 15576320.
17. Engel J, Balachandran P, (2009) Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 12: 61-66. doi:10.1016/j.mib.2008.12.007. PubMed: 19168385.
18. Giraud C, Bernard CS, Ruer S, de Bentzmann S, (2010) Biological "glue" and "Velcro": molecular tools for adhesion and biofilm formation in the hairy and gluey bug Pseudomonas aeruginosa. Environ Microbiol Rep 2: 343-358. PubMed: 23766107.
19. McCarty SM, Cochrane CA, Clegg PD, Percival SL, (2012) The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing. Wound Rep Reg 20: 125-136. doi:10.1111/j.1524-475X.2012.00763.x. PubMed: 22380687.
20. Supuran CT, Scozzafava A, Clare BW, (2002) Bacterial protease inhibitors. Med Res Rev 22: 329-372. doi:10.1002/med.10007. PubMed: 12111749.
21. Leduc D, Beaufort N, de Bentzmann S, Rousselle JC, Namane A, et al. (2007) The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis. Infect Immun 75: 3848-3858. doi:10.1128/IAI.00015-07. PubMed: 17517866.
22. Cabrol S, Olliver A, Pier GB, Andremont A, Ruimy R, (2003) Transcription of quorum-sensing system genes in clinical and environmental isolates of Pseudomonas aeruginosa. J Bacteriol 185: 7222-7230. doi:10.1128/JB.185.24.7222-7230.2003. PubMed: 14645283.
23. Jyot J, Balloy V, Jouvion G, Verma A, Touqui L, et al. (2011) Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection. J Infect Dis 203: 369-377.
24. Potempa J, Pike RN, (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1: 70-87. doi:10.1159/000181144. PubMed: 19756242.
25. Komori Y, Nonogaki T, Nikai T, (2001) Hemorragic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 39: 1327-1332. doi:10.1016/S0041-0101(01)00084-8. PubMed: 11384720.
26. Sheets SM, Potempa J, Travis J, Casiano CA, Fletcher HM, (2005) Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect Immun 73: 1543-1552. doi:10.1128/IAI.73.3.1543-1552.2005. PubMed: 15731052.
27. Takii R, Kadowaki T, Baba A, Tsukuba T, Yamamoto K, (2005) A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems. Infect Immun 73: 883-893. doi:10.1128/IAI.73.2.883-893.2005. PubMed: 15664930.
28. Valente E, Assis MC, Alvim IMP, Pereira GMB, Plotkowski MC, (2000) Pseudomonas aeruginosa induces apoptosis in human endothelial cells. Microb Pathog 29: 345-356. doi:10.1006/mpat.2000.0400. PubMed: 11095919.
29. Beaufort N, Corvazier E, Hervieu A, Choqueux C, Dussiot M, et al. (2011) The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic Pseudomonas aeruginosa induces anoikis of human vascular cells. Cell Microbiol 13: 1149-1167. doi:10.1111/j.1462-5822.2011.01606.x. PubMed: 21501369.
30. McIver KS, Kessler E, Olson JC, Ohman DE, (1995) The elastase propeptide functions as an intramolecular chaperone required for elastase activity and secretion in Pseudomonas aeruginosa. Mol Microbiol 18: 877-889. doi:10.1111/j.1365-2958.1995.18050877.x. PubMed: 8825092.
31. de Bentzmann S, Polette M, Zahm JM, Hinnrasky J, Kileztky C, et al. (2000) Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Lab Invest 80: 209-219. doi:10.1038/labinvest.3780024. PubMed: 10701690.
32. Beaufort N, Seweryn P, de Bentzmann S, Tang A, Kellermann J, et al. (2010) Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa. Biochem J 428: 473-482. doi:10.1042/BJ20091806. PubMed: 20337595.
33. Caballero AR, Moreau JM, Engel LS, Marquart ME, Hill et al,. (2001) Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases. Anal Biochem 290: 330-337. doi:10.1006/abio.2001.4999. PubMed: 11237336.
34. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872-1874. PubMed: 16141364.
35. Maubant S, Saint-Dizier D, Boutillon M, Perron-Sierra F, Casara PJ, et al. (2006) Blockade of αvβ3 and αvβ5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells. Blood 108: 3035-3044. doi:10.1182/blood-2006-05-023580. PubMed: 16835373.
36. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW, (2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276: 11199-11203. doi:10.1074/jbc.C100017200. PubMed: 11278252.
37. Ray MJ, Marsh NA, (1997) Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin. Thromb Haemost 78: 1021-1026. PubMed: 9308747.
38. Koolwijk P, Sidenius N, Peters E, Sier CFM, Hanemaaijer R, et al. (2001) Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. Blood 97: 3123-3131. doi:10.1182/blood.V97.10.3123. PubMed: 11342439.
39. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, et al. (2002) The immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 168: 5989-5992. PubMed: 12055204.
40. Carey DJ, (1991) Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 53: 161-177. doi:10.1146/annurev.ph.53.030191.001113. PubMed: 2042957.
41. Rand JH, Glanville RW, Wu X-X, Ross JM, Zangari M, et al. (1997) The significance of subendothelial von Willebrand factor. Thromb Haemost 78: 445-450. PubMed: 9198194.
42. Ruggeri ZM, (1999) Structure and function of von Willebrand factor. Thromb Haemost 82: 576-584. PubMed: 10605754.
43. Wagner DD, Urban-Pickering M, Marder VJ, (1984) von Willebrand protein binds to extracellular matrices independently of collagen. Proc Natl Acad Sci U S A 81: 471-475. doi:10.1073/pnas.81.2.471. PubMed: 6320190.
44. Buzza MS, Zamurs L, Sun J, Bird CH, Smith AI, et al. (2005) Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J Biol Chem 280: 23549-23558. doi:10.1074/jbc.M412001200. PubMed: 15843372.
45. Herren B, Levkau B, Raines EW, Ross R, (1998) Cleavage of β-catenin and plakoglobin and shedding of VE-cadherin durin endothelial apoptosis: evidence for a role of caspases and metalloproteinases. Mol Biol Cell 9: 1589-1601. doi:10.1091/mbc.9.6.1589. PubMed: 9614196.
46. Moura-da-Silva AM, Butera D, Tanjoni I, (2007) Importance of snake venom metalloproteinases in cell biology: effects on platelets, inflammatory and endothelial cells. Curr Pharm Des 13: 2893-2905. doi:10.2174/138161207782023711. PubMed: 17979734.
47. Schubert-Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, et al. (2010) Neisseria meningitides induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role of MMP-8. PLOS Pathog 6: e1000874.
48. Vestweber D, (2008) VE-cadherin. The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28: 223-232. PubMed: 18162609.
49. Dejana E, Tournier-Lasserve E, Weinstein BM, (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16: 209-221. doi:10.1016/j.devcel.2009.01.004. PubMed: 19217423.
50. Sidibé A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, et al. (2012) Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity. Arthritis Rheum 64: 77-87. doi:10.1002/art.33336. PubMed: 21905018.
51. Xiao K, Allison DF, Kottke MD, Summers S, Sorescu GP, et al. (2003) Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells. J Biol Chem 278: 19199-19208. doi:10.1074/jbc.M211746200. PubMed: 12626512.
52. Bojarski C, Weiske J, Schöneberg T, Schröder W, Mankertz J, et al. (2004) The specific fates of tight junction proteins in apoptotic epithelial cells. J Cell Sci 117: 2097-2107. doi:10.1242/jcs.01071. PubMed: 15054114.
53. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA, (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27: 697-709. PubMed: 16850029.
54. Alghisi GC, Rüegg C, (2006) Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium 13: 113-135. doi:10.1080/10623320600698037. PubMed: 16728329.
55. Binder BR, Mihaly J, Prager GW, (2007) uPAR - uPA - PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 97: 336-342. PubMed: 17334498.
56. Blasi F, Sidenius N, (2010) The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett 584: 1923-1930. doi:10.1016/j.febslet.2009.12.039. PubMed: 20036661.
57. Smith HW, Marshall CJ, (2010) Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11: 23-36. doi:10.1038/nrm2821. PubMed: 20027185.
58. Colman RW, Wu Y, Liu Y, (2010) Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signaling. Thromb Haemost 104: 875-885. doi:10.1160/TH10-01-0017. PubMed: 20886177.
59. Alfano D, Iaccarino I, Stoppelli MP, (2006) Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels. J Biol Chem 281: 17758-17767. doi:10.1074/jbc.M601812200. PubMed: 16632475.
60. Prager GW, Mihaly J, Brunner PM, Koshelnick Y, Hoyer-Hansen G, et al. (2009) Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein. Blood 113: 1383-1390. doi:10.1182/blood-2008-06-164210. PubMed: 18948573.
61. Hsu SL, Cheng CC, Shi YR, Chiang CW, (2001) Proteolysis of integrin α5 and β1 subunits involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Cancer Lett 167: 193-204. doi:10.1016/S0304-3835(01)00479-7. PubMed: 11369141.
62. Stepińska M, Trafny EA, (2008) Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines. Microb Pathog 44: 448-458. doi:10.1016/j.micpath.2007.11.008. PubMed: 18221854.
63. Mattos Saliba A, Filloux A, Ball G, Silva ASV, Assis M-C, et al. (2009) Type III secretion-mediated killing of endothelial cells by Pseudomonas aeruginosa. Microb Pathog 33: 153-166.
64. Boehme MWJ, Galle P, Stremmel W, (2002) Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 107: 340-349. doi:10.1046/j.1365-2567.2002.01469.x. PubMed: 12423310.
65. Tournier J-M, Jacquot J, Puchelle E, Bieth JG, (1985) Evidence that Pseudomonas aeruginosa elastase does not inactivate the bronchial inhibitor in the presence of leukocyte elastase. Am Rev Respir Dis 132: 524-528. PubMed: 2412473.
66. Basire A, Sabatier F, Ravet S, Lamy E, Mialhe A, et al. (2006) High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thromb Haemost 95: 678-688. PubMed: 16601839.
67. Meredith JE Jr, Fazeli B, Schwartz MA, (1993) The extracellular matrix as a cell survival factor. Mol Biol Cell 4: 953-961. doi:10.1091/mbc.4.9.953. PubMed: 8257797.
68. Chung M-C, Popova TG, Jorgensen SC, Dong L, Chandhoke V, et al. (2008) Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy. J Biol Chem 283: 9531-9542. doi:10.1074/jbc.M705871200. PubMed: 18263586.
69. Hermant B, Bibert S, Concord E, Dublet B, Weidenhaupt M, et al V,. (2003) Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J Biol Chem 278: 14002-14012. doi:10.1074/jbc.M300351200. PubMed: 12584200.
70. Attali C, Durmort C, Vernet T, Di Guilmi A-M, (2008) The interaction of Streptocccus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect Immun 76: 5350-5356. doi:10.1128/IAI.00184-08. PubMed: 18725422.
71. Zulianello L, Canard C, Köhler T, Caille D, Lacroix J-S, et al. (2006) Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect Immun 74: 3134-3147. doi:10.1128/IAI.01772-05. PubMed: 16714541.
72. Vasil ML, Stonehouse MJ, Vasil AI, Wadsworth SJ, Goldfine H, et al. (2009) A complex extracellular sphingomyelinase of Pseudomonas aeruginosa inhibits angiogenesis by selective cytotoxicity to endothelial cells. PLOS Pathog 5(5):: e1000420. PubMed: 19424430.
73. Shafikhani SH, Engel J, (2006) Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps. Proc Natl Acad Sci U S A 103: 15605-15610. doi:10.1073/pnas.0605949103. PubMed: 17030800.